Results 71 to 80 of about 1,304 (177)

Effects of Dexamethasone on Neuromuscular Transmission in a Phrenic Nerve-Hemidiaphragm Preparation in the Rat [PDF]

open access: yes, 2003
Background: MacFarlane and Rosenthal reported a case of acute quadriplegia after nondepolarizing muscular blocking agents in status asthmaticus patient treated with high doses of corticosteroid.
신양식
core  

The association between non-depolarizing neuromuscular blockade agents and survival to discharge in dogs undergoing mechanical ventilation: a multi-center retrospective study of 227 dogs (2010–2020)

open access: yesFrontiers in Veterinary Science
ObjectiveTo evaluate the association between neuromuscular blockade agent (NMBA) use and outcome in dogs undergoing mechanical ventilation (MV), including survival to discharge, and complications.MethodsThe medical records for 227 mechanically ventilated
Lena Ngo   +9 more
doaj   +1 more source

Severe Repeated Hypotension Occurred after Rocuronium Administrations in a Morbidly Obese Patient: A Case Report

open access: yes, 2014
Rocuronium has the most rapid onset of action among the nondepolarizing neuromuscular blocking drugs; doses of 0.6-0.9 mg/ Kg guarantee a complete block in about 60-90 seconds and good or excellent intubating conditions in 60 seconds [1,2].Its ...
Giovanni Rosa   +5 more
core   +1 more source

Effect of cisatracurium versus atracurium on intraocular pressure in patients undergoing tracheal intubation for general anesthesia

open access: yesJournal of Research in Medical Sciences, 2011
Background: Increase in intraocular pressure (IOP) following tracheal intubation during general anesthesia can be troublesome. We compared the influence of two muscle relaxants, cisatracurium and atracurium, on IOP in patients undergoing general ...
Mitra Jabalameli   +3 more
doaj  

CLINICAL OBSERVATIONS ON THE NEUROMUSCULAR BLOCKING ACTION OF ORG 9426, A NEW STEROIDAL NON-DEPOLARIZING AGENT

open access: yesBritish Journal of Anaesthesia, 1990
The neuromuscular blocking effects of Org 9426, the 2-morpholino, 16-allyl-pyrrolidino derivative of the 3-desacetoxy analogue of vecuronium have been investigated in anaesthetized patients. Based on data from a pilot study, two doses, 250 and 500 micrograms kg-1 (estimated as the ED90 and 2 x ED90, respectively) were chosen.
WIERDA, JMKH   +3 more
openaire   +3 more sources

A 63-Year-Old Male with Severe Flaccid Weakness Post Motor Vehicle Accident

open access: yes, 2016
Neuromuscular disorders are important causes of newly acquired weakness in the intensive care unit. Although evaluation usually begins with physical examination findings, these can be compromised in the intensive care unit environment.
Jeffrey A. Cohen   +3 more
core   +1 more source

Pharmacodynamics of vecuronium bromide in anaesthetized neonates, infants and children [PDF]

open access: yes, 1988
Since the introduction of muscle relaxants in clinical paediatric anaesthesia (Chapter I) controversies concerning their potency and pharmacodynamic behaviour have remained.
Schippers, H.C. (Houkje)
core  

Sugammadex Versus Neostigmine In Reducing Postoperative Adverse Effects In The Pediatric Population

open access: yes, 2020
Neostigmine and sugammadex are two medications used to reverse the neuromuscular blockade caused by nondepolarizing aminosteroidal neuromuscular blocking agents.
Vieto, Robert, Jr.
core  

Delayed-Onset Malignant Hyperthermia in Association with Rocuronium Use

open access: yes, 2012
Purpose Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing neuromuscular blocker are reported. Summary A pharmacogenetic disorder that may occur in as many as 1 in 3000 anesthesia procedures, malignant ...
Beggs, Ashton E.   +2 more
core   +1 more source

Open-Globe Eye Injuries and Choice of Muscle Relaxant: A Review of the Evidence

open access: yes, 2014
A goal of treatment of open-globe eye injuries is preventing rises in intraocular pressure and the resulting loss of vitreous humor fluid from the eye globe.
Benoit, BSN, RRNA, Joelle   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy